Autres langues Pacific Shuanglin Bio-pharmacy Co., LTD

Actions

000403

CNE000000F14

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
29,29 ^CNY	-1,61%		-1,94%	+7,53%

26/04	Pacific Shuanglin Bio-pharmacy Co. LTD présente ses résultats pour le premier trimestre clos le 31 mars 2024	CI
15/04	Les bénéfices de Pacific Shuanglin Bio-pharmacy pour 2023 augmentent de 4 % malgré une baisse des revenus ; les actions progressent de 4 %.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4%	15/04
Pacific Shuanglin Bio-pharmacy's Profit Seen More Than Doubling in Q1; Shares Up 3%	15/04
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	12/04
Pacific Shuanglin Bio-pharmacy Co., LTD announced a financing transaction	23/02
Pacific Shuanglin Bio-pharmacy Unit Gets Nod to Trial Human Coagulation Factor IX	06/11
Pacific Shuanglin Bio-pharmacy Co., LTD Approves Board Appointments	26/10/23
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	18/10/23
Pacific Shuanglin Bio-pharmacy Obtains Another Blood Collection License	22/09/23
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23
Pacific Shuanglin Bio-pharmacy Obtains Blood Plasma Collection License	08/08/23
Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.	21/07/23
Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback announced on September 1, 2022 has expired with 1,968,378 shares, representing 0.27% for CNY 40.1 million.	20/07/23
Pacific Shuanglin Bio-Pharmacy Co., Ltd Announces Final Dividend Implementation on A Shares for the Year 2022, Payable on July 20, 2023	14/07/23
Tranche Update on Pacific Shuanglin Bio-pharmacy Co., LTD's Equity Buyback Plan announced on September 1, 2022.	03/07/23
Pacific Shuanglin Bio-pharmacy's Unit Gets Permit to Operate Two Plasma Hubs	26/05/23
Pacific Shuanglin Bio-Pharmacy Co., Ltd Approves 2022 Profit Distribution Plan	23/05/23
Gongqingcheng Shengbang Yinghao Investment Partnership (Limited Partnership) completed the acquisition of 20.99% stake in Pacific Shuanglin Bio-pharmacy Co., LTD from Hangzhou Zhemintou Tianhong Investment Partnership Enterprise (LP) and Zhejiang Private Enterprise United Investment Co., Ltd.	23/05/23
Pacific Shuanglin Bio-pharmacy Registers Blood Clotting Drug	18/05/23
Pacific Shuanglin Bio-pharmacy Signs Drug Supply, Distribution Deal With Brazil’s Hypera Pharma	05/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pacific Shuanglin Bio-pharmacy Co., LTD

Actions

000403

CNE000000F14

Autres langues

Filtres